Bicara Therapeutics Inc (BCAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BCAX | URGN | GHRS | ||
| Company | Bicara Therapeutics Inc | Urogen Pharma Ltd | Gh Research Plc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 20.92 | 29.00 | 23.14 | ||
| High | 20.92 | 29.25 | 23.75 | ||
| Low | 19.20 | 28.18 | 21.07 | ||
| Latest | 19.29 | 28.58 | 21.68 | ||
| Change | -0.94 | -0.20 | +0.29 | ||
| % Change | -4.65% | -0.69% | +1.36% | ||
| Volume | 571,800 | 830,700 | 373,800 | ||
| 20-Day Average Volume | 517,700 | 1,005,100 | 230,375 | ||
| Previous Close | 20.23 | 28.78 | 21.39 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 22.15 | 26.30 | 20.82 | ||
| 20-Day Raw Stochastic | 1.88% | 61.17% | 61.51% | ||
| 20-Day Relative Strength | 40.35 | 61.82 | 60.60 | ||
| Weighted Alpha | +54.90 | +171.13 | +105.91 | ||
| Today's Opinion | 56% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 64% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 8% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -15.84% since 05/11/26 | -8.78% since 05/11/26 | +1.98% since 05/11/26 | ||
| Low | 19.20 on 05/18/26 | 28.18 on 05/18/26 | 20.00 on 05/14/26 | ||
| High | 22.93 on 05/12/26 | 31.32 on 05/13/26 | 23.75 on 05/18/26 | ||
| 1-Month | |||||
| %Chg | -19.66% since 04/17/26 | +26.80% since 04/17/26 | +18.21% since 04/17/26 | ||
| Low | 19.20 on 05/18/26 | 22.07 on 04/20/26 | 18.38 on 04/23/26 | ||
| High | 23.99 on 04/23/26 | 32.37 on 05/11/26 | 24.66 on 04/20/26 | ||
| 3-Month | |||||
| %Chg | +33.13% since 02/18/26 | +28.33% since 02/18/26 | +34.66% since 02/18/26 | ||
| Low | 14.15 on 02/19/26 | 16.50 on 03/30/26 | 12.77 on 03/24/26 | ||
| High | 24.25 on 04/17/26 | 32.37 on 05/11/26 | 24.66 on 04/20/26 | ||
| 6-Month | |||||
| %Chg | +23.89% since 11/18/25 | +21.36% since 11/18/25 | +57.67% since 11/18/25 | ||
| Low | 13.75 on 02/17/26 | 16.50 on 03/30/26 | 12.04 on 12/16/25 | ||
| High | 24.25 on 04/17/26 | 32.37 on 05/11/26 | 24.66 on 04/20/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,329,192 | 1,402,219 | 1,326,800 | ||
| Shares Outstanding, K | 65,704 | 48,722 | 62,029 | ||
| Annual Sales | 0 | 109,790,000 | 0 | ||
| Annual Net Income | -137,950,000 | -153,490,000 | -48,260,000 | ||
| Last Quarter Sales | 0 | 50,960,000 | 0 | ||
| Last Quarter Net Income | -37,390,000 | -23,570,000 | -14,140,000 | ||
| 60-Month Beta | -0.57 | 1.58 | 1.27 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.93 on 05/11/26 | -0.47 on 05/06/26 | -0.23 on 03/05/26 | ||
| Earnings Date | 08/11/26 | 08/06/26 | 08/06/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||